ORIX Life Insurance Launches New Medical Insurance "New CURE Support" and Whole Life Insurance "New RISE Support"

TOKYO, Japan - August 24, 2015 - ORIX Life Insurance Corporation ("ORIX Life"), a subsidiary of ORIX Corporation announced today that it will launch medical insurance "New CURE Support" and whole life insurance "New RISE Support" on October 2, 2015.

"Cure Support," launched in October 2011, is a medical insurance with relaxed underwriting conditions that was developed with an aim to provide medical coverage to customers who were unable to purchase medical insurance due to their health conditions. Similarly, "Rise Support," launched in October 2011, is a whole life insurance with relaxed underwriting conditions that was developed with an aim to provide whole life coverage to customers who were unable to purchase whole life insurance from other insurance companies.

The former has been reborn as medical insurance "New CURE Support" after going through a significant revision of its coverage including the addition of the "Hospitalization Benefit for the Seven Lifestyle-Related Diseases Act (Unlimited for the Three Major Diseases)" that covers an unlimited number of hospitalization days due to cancer, heart disease, and stroke (the three major diseases) and the "Relaxed Underwriting Conditions with Lump-Sum Payment for the Severe Three Diseases Rider" that pays an unlimited number of lump-sum payments if diagnosed with cancer, acute myocardial infarction, or cerebral stroke (the severe three diseases).

Furthermore, the renewed Medical Insurance "New CURE Support" and Whole Life Insurance "New RISE Support" are expected to gather interests from wider range of customers through the new feature "Premium Waiver for Specified Diseases Act" where, in the event the insured reaches a state prescribed by ORIX Life as a result of cancer, heart disease, or stroke, future premium payments will be exempt.

ORIX Life will continue to develop insurance products fine-tuned to customer needs, while further enhancing service quality, with the view to becoming a life insurer that delivers true customer satisfaction.

(*) With the launch of the foregoing products, ORIX Life will discontinue sales of "CURE Support" and "RISE Support" on October 1, 2015.

(Product outline of New CURE Support)

■ Outline of coverage

1. Lifelong protection is provided for hospitalization and surgery due to illness or injury (For hospitalization, coverage is provided from day one).
2.Limit on the number of days of hospitalization covered due to the seven lifestyle-related diseases has been extended and protection is provided for an unlimited number of days of hospitalization due to the three major diseases.(if the Hospitalization Benefit for the Seven Lifestyle-Related Diseases Act is applied).
3. Linked to the national medical insurance system, a maximum surgical procedure benefit equivalent to ten times the amount of the hospitalization benefit will be paid in case of a surgery during hospitalization and a maximum surgical procedure benefit equivalent to five times the amount of the daily hospitalization will be paid in case of a surgery as outpatient.
4. The "Premium Waiver for Specified Diseases Act" exempting policyholders from future premium payments if diagnosed with prescribed conditions as a result of cancer, acute myocardial infraction or cerebral stroke can be applied.
5. The "Relaxed Underwriting Conditions with Lump-Sum Payment for the Severe Three Diseases Rider" providing a lump-sum payment if suffering from cancer, acute myocardial infarction, or cerebral stroke has been newly set up.
6. The "Relaxed Underwriting Conditions with Lump-Sum Payment for Cancer Rider" providing a lump-sum payment if suffering from cancer has been newly set up.
7. The "Relaxed Underwriting Conditions with Advanced Medical Treatment Rider" and the "Relaxed Underwriting Conditions with Whole Life Insurance Rider" can be attached.
8. The maximum issue age has been raised from 80 to 85.

　* Certain conditions differ in the case of mail order applications.

(Product outline of New RISE Support)

■ Revisions
1. The "Premium Waiver for Specified Diseases Act" exempting policyholders from future premium payments if diagnosed with prescribed conditions as a result of cancer, acute myocardial infraction or cerebral stroke can be applied.
2. The maximum issue age has been raised from 80 to 85.

* Certain conditions differ in the case of mail order applications.

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group that provides innovative products and services to its customers by constantly pursuing new businesses. Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into the lending, investment, life insurance, banking, asset management, automobile-related, real estate and environment and energy-related businesses. Since its first overseas expansion into Hong Kong in 1971, ORIX has spread its business globally by establishing locations in a total of 36 countries and regions across the world. Moving forward, ORIX aims to contribute to society while continuing to capture new business opportunities. For more details, please visit our website: http://www.orix.co.jp/grp/en/

Caution Concerning Forward-Looking Statements:
These documents may contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under "Risk Factors" in the Company's annual report on Form 20-F filed with the United States Securities and Exchange Commission and under "4. Risk Factors" of the "Summary of Consolidated Financial Results" of the "Consolidated Financial Results April 1, 2014 - March 31, 2015."